Australia, Oct. 7 -- Kyverna Therapeutics Inc., owns the trademark (2675466) for 'MIVSET' till May 7, 2036.
Status: protected:
Registered/protected
Class: 5 [Therapeutic pharmaceuticals for the treatment of autoimmune diseases; therapeutic pharmaceuticals and cell therapy products in the nature of cells for medical or clinical use for the treatment of autoimmune disease; cell therapy products, namely, genetically engineered immune cells for medical or clinical use for the treatment of autoimmune disease; pharmaceutical preparations and substances for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of immune sy...